Eylea® hd (aflibercept) injection 8 mg two-year results from pivotal pulsar trial in wet age-related macular degeneration presented at euretina

First presentation of long-term results demonstrated sustained visual and anatomic improvements among eylea hd patients through two years first presentation of long-term results demonstrated sustained visual and anatomic improvements among eylea hd patients through two years
REGN Ratings Summary
REGN Quant Ranking